BRCA germline mutations in an unselected nationwide cohort of Chinese patients with ovarian cancer and healthy controls

Abstract

We recommend BRCA testing to all Chinese OC patients and those general Chinese who have family members with hereditary breast and ovarian related cancer (HBOC)-related cancers. Variants carriers would not only benefit from early prevention of OC but also for the medical management.